Loxo Oncology Lands $33,000,000 Series A Funding Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=fe5cd32d-7f48-447b-b6f8-814635f9a6d1 - Date
10/4/2013 - Company Name
Loxo Oncology - Mailing Address
Undisclosed New York, NY 10467 - Company Description
Loxo Oncology was incorporated in Delaware in May 2013 and was founded by Josh Bilenker, M.D., a partner at Aisling Capital. Loxo Oncology is committed to bringing targeted cancer therapies rapidly into the clinic that have an opportunity for outsized clinical effects in genetically defined patient populations. - Website
Undisclosed
- Transaction Type
Venture Equity - Transaction Amount
$33,000,000 - Transaction Round
Series A - Proceeds Purposes
This funding allows us to advance our pipeline on multiple fronts. - M&A Terms
- Venture Investor
Aisling Capital - Venture Investor
OrbiMed Advisors
